Bioatla Inc expected to post a loss of 80 cents a share - Earnings Preview

Bioatla

04/11/2023 02:16

* Bioatla Inc  BCAB.OQ   BCAB.O  is expected to show no
change in
quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Bioatla Inc is for
a loss
of 80 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioatla Inc
is
$13.5​, above​ its last closing price of $1.85. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.63       -0.64      -0.75     Missed  -17.2
 Mar. 31 2023  -0.63       -0.63      -0.58     Beat    7.6
 Dec. 31 2022  -0.62       -0.70      -0.63     Beat    9.7​
 Sep. 30 2022  -0.80       -0.80      -0.69     Beat    13.8
 ​​Jun.        -0.70       -0.69      -0.77     Missed  -12.3
 30 2022                                                
 Mar. 31 2022  -0.67       -0.67      -0.65     Beat    3​
 Dec. 31 2021  -0.63       -0.63      -0.62     Beat    1.2
 Sep. 30 2021  -0.63       -0.64      -0.68     Missed  -5.7
 This summary was machine generated November 4 at 02:16 GMT.  All
figures in US dollars  unless otherwise stated